Comprehensive Analysis of Baseline Risk Factors Associated with Poor Outcomes and Development of the First Staging System for Primary Plasma Cell Leukemia: A Retrospective, Multicenter, Cohort Study
Mengru Tian(Jilin University), Fengyan Jin(North China University of Science and Technology), Chunrui Li(Tongji Hospital), Shaji Kumar(Mayo Clinic), Gang An(RAM Laboratories (United States)), Yun Dai(University of Miami), Shanshan Yu(Jilin University), Xinyue Liang(Shanghai University), Weijun Fu(Shanghai Changzheng Hospital), Wenqiang Yan(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Lü(Tongji Hospital), Aijun Liao(First Affiliated Hospital of University of South China), Chengcheng Fu(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Guangxun Gao(Xijing Hospital), Shuling Hou(Shanxi Academy of Medical Sciences), Li Gao(Army Medical University), Zhenyu Li(Xuzhou Medical College), Mengyao Li(Tianjin University of Traditional Chinese Medicine), Fan Zhou(University of Electronic Science and Technology of China), Lijuan Chen(Zhengzhou University), Xiaotao Wang(Sun Yat-sen University), Hua Wang(Chinese Academy of Sciences), He Aili, Hui Zeng(Dalian Medical University), Yi Wang(Shanxi Medical University), Chunyan Sun(Union Hospital), Xiaoqi Qin(Shanxi Medical University), Yongqiang Wei(Southern Medical University), Hua Xue(Hebei Medical University), Dongmei Guo(Zhongshan Hospital of Xiamen University), Yujun Dong(Peking University), Jian‐Qing Mi(Shanghai Jiao Tong University), Xiaoxia Chu(Yuhuangding Hospital), Zhihong Fang(First Affiliated Hospital of Xiamen University), Lugui Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 0
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965